These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15862964)

  • 21. A comparative study of canine and human breast cancer.
    Owen LN
    Invest Cell Pathol; 1979; 2(4):257-75. PubMed ID: 396282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
    de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
    Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
    Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrinology of reproduction in the female beagle dog and its significance in mammary gland tumorigenesis.
    Gräf KJ; El Etreby MF
    Acta Endocrinol Suppl (Copenh); 1979; 222():1-34. PubMed ID: 285559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
    Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
    Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin--to be reconsidered in canine mammary tumourigenesis?
    Michel E; Rohrer Bley C; Kowalewski MP; Feldmann SK; Reichler IM
    Vet Comp Oncol; 2014 Jun; 12(2):93-105. PubMed ID: 22738741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
    Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
    Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop.
    van Garderen E; de Wit M; Voorhout WF; Rutteman GR; Mol JA; Nederbragt H; Misdorp W
    Am J Pathol; 1997 Mar; 150(3):1037-47. PubMed ID: 9060840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.
    Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Lopes CS; Illera JC
    Res Vet Sci; 2010 Dec; 89(3):396-403. PubMed ID: 20381105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
    Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog.
    Marinelli L; Gabai G; Wolfswinkel J; Mol JA
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):167-73. PubMed ID: 15555910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral melatonin administration on sex hormone, prolactin, and thyroid hormone concentrations in adult dogs.
    Ashley PF; Frank LA; Schmeitzel LP; Bailey EM; Oliver JW
    J Am Vet Med Assoc; 1999 Oct; 215(8):1111-5. PubMed ID: 10530323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid metabolism and oestradiol-17beta binding in canine mammary tumours [proceedings].
    Evans BA; Borthwick G; Wilson DW; Pierrepoint CG
    J Endocrinol; 1978 May; 77(2):64P-65P. PubMed ID: 660072
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum neopterin levels in female dogs with malignant mammary tumours.
    Szczubiał M; Dąbrowski R; Łopuszyński W
    Vet Comp Oncol; 2014 Jun; 12(2):143-8. PubMed ID: 22882538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.